AI in personalized cancer medicine: New therapies require flexible and safe approval conditions
by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The
Updated on: March 05,2024
11

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions
by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The
Updated on:March 05,2024
11
